GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Other Current Payables

Moss Genomics (XCNQ:MOSS) Other Current Payables : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Other Current Payables?

Moss Genomics's Other Current Payables for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Moss Genomics Other Current Payables Historical Data

The historical data trend for Moss Genomics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Other Current Payables Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Other Current Payables
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Moss Genomics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Moss Genomics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines